These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7723779)
1. Minimal variation in the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum. Kocken CH; Milek RL; Lensen TH; Kaslow DC; Schoenmakers JG; Konings RN Mol Biochem Parasitol; 1995 Jan; 69(1):115-8. PubMed ID: 7723779 [No Abstract] [Full Text] [Related]
2. Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate. Drakeley CJ; Duraisingh MT; Póvoa M; Conway DJ; Targett GA; Baker DA Mol Biochem Parasitol; 1996 Oct; 81(2):253-7. PubMed ID: 8898341 [No Abstract] [Full Text] [Related]
3. Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast. Milek RL; Stunnenberg HG; Konings RN Vaccine; 2000 Jan; 18(14):1402-11. PubMed ID: 10618538 [TBL] [Abstract][Full Text] [Related]
4. Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques. Datta D; Bansal GP; Grasperge B; Martin DS; Philipp M; Gerloff D; Ellefsen B; Hannaman D; Kumar N Vaccine; 2017 Dec; 35(50):7049-7056. PubMed ID: 29132995 [TBL] [Abstract][Full Text] [Related]
5. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine. Theisen M; Jore MM; Sauerwein R Expert Rev Vaccines; 2017 Apr; 16(4):329-336. PubMed ID: 28043178 [TBL] [Abstract][Full Text] [Related]
6. [Cloning and sequencing of the gene coding the sexual stage antigen Pfs48/45 of Plasmodium falciparum]. Luo S; Yu X; Liu Y; Fang J; Xu J; Li X Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(6):406-10. PubMed ID: 12078283 [TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Kocken CH; Jansen J; Kaan AM; Beckers PJ; Ponnudurai T; Kaslow DC; Konings RN; Schoenmakers JG Mol Biochem Parasitol; 1993 Sep; 61(1):59-68. PubMed ID: 8259133 [TBL] [Abstract][Full Text] [Related]
9. Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45. Kundu P; Semesi A; Jore MM; Morin MJ; Price VL; Liang A; Li J; Miura K; Sauerwein RW; King CR; Julien JP Nat Commun; 2018 Oct; 9(1):4458. PubMed ID: 30367064 [TBL] [Abstract][Full Text] [Related]
10. Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. Outchkourov NS; Roeffen W; Kaan A; Jansen J; Luty A; Schuiffel D; van Gemert GJ; van de Vegte-Bolmer M; Sauerwein RW; Stunnenberg HG Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4301-5. PubMed ID: 18332422 [TBL] [Abstract][Full Text] [Related]
11. Extreme geographical fixation of variation in the Plasmodium falciparum gamete surface protein gene Pfs48/45 compared with microsatellite loci. Conway DJ; Machado RL; Singh B; Dessert P; Mikes ZS; Povoa MM; Oduola AM; Roper C Mol Biochem Parasitol; 2001 Jul; 115(2):145-56. PubMed ID: 11420101 [TBL] [Abstract][Full Text] [Related]
12. Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite. Mistarz UH; Singh SK; Nguyen TTTN; Roeffen W; Yang F; Lissau C; Madsen SM; Vrang A; Tiendrebeogo RW; Kana IH; Sauerwein RW; Theisen M; Rand KD Pharm Res; 2017 Sep; 34(9):1970-1983. PubMed ID: 28646324 [TBL] [Abstract][Full Text] [Related]
13. Diversity of Plasmodium falciparum vaccine candidate merozoite surface protein 4 (MSP4) in a natural population. Benet A; Tavul L; Reeder JC; Cortés A Mol Biochem Parasitol; 2004 Apr; 134(2):275-80. PubMed ID: 15003847 [No Abstract] [Full Text] [Related]
14. Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Templeton TJ; Kaslow DC Mol Biochem Parasitol; 1999 Jun; 101(1-2):223-7. PubMed ID: 10413057 [No Abstract] [Full Text] [Related]
15. Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum. Marshall VM; Zhang L; Anders RF; Coppel RL Mol Biochem Parasitol; 1996 Apr; 77(1):109-13. PubMed ID: 8784778 [No Abstract] [Full Text] [Related]
16. Pfs47, paralog of the male fertility factor Pfs48/45, is a female specific surface protein in Plasmodium falciparum. van Schaijk BC; van Dijk MR; van de Vegte-Bolmer M; van Gemert GJ; van Dooren MW; Eksi S; Roeffen WF; Janse CJ; Waters AP; Sauerwein RW Mol Biochem Parasitol; 2006 Oct; 149(2):216-22. PubMed ID: 16824624 [TBL] [Abstract][Full Text] [Related]
17. Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. Roeffen WF; Raats JM; Teelen K; Hoet RM; Eling WM; van Venrooij WJ; Sauerwein RW J Biol Chem; 2001 Jun; 276(23):19807-11. PubMed ID: 11279092 [TBL] [Abstract][Full Text] [Related]
18. Limited polymorphism of the vaccine candidate merozoite surface protein 4 of Plasmodium falciparum. Wang L; Marshall VM; Coppel RL Mol Biochem Parasitol; 2002 Apr; 120(2):301-3. PubMed ID: 11897136 [No Abstract] [Full Text] [Related]
19. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display. Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824 [TBL] [Abstract][Full Text] [Related]
20. Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum. Shi YP; Alpers MP; Povoa MM; Lal AA Mol Biochem Parasitol; 1992 Jan; 50(1):179-80. PubMed ID: 1542311 [No Abstract] [Full Text] [Related] [Next] [New Search]